OKYO (OKYO Pharma) Total Receivables: $0.02 Mil (As of Sep. 2025)


OKYO OKYO Pharma Ltd OKYO
23 GF Score
Price $1.69
! 3 Warning Signs
View Full Analysis

What is OKYO Pharma Total Receivables?

OKYO Pharma OKYO +1.20% 23 Total Receivables is $0.02 Mil as of Sep. 2025. GuruFocus rates OKYO with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

OKYO Pharma's Total Receivables for the quarter that ended in Sep. 2025 was $0.02 Mil.

OKYO Pharma Total Receivables Historical Data

* Premium members only.

The historical data trend for OKYO Pharma's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OKYO Pharma Total Receivables Chart

OKYO Pharma Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.88 0.98 0.58 1.89

OKYO Pharma Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.58 1.52 1.89 0.02
OKYO
23GF Score
OKYO Pharma Ltd OKYO
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OKYO Pharma Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of $0.02 Mil mean?
OKYO Pharma (OKYO) has a Total Receivables of $0.02 Mil as of Sep. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on OKYO Pharma and its competitors.
Is OKYO Pharma's Total Receivables too high?
OKYO Pharma's current Total Receivables is $0.02 Mil. Overall, OKYO Pharma has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does OKYO Pharma's Total Receivables compare to ENTX and HRTX?
OKYO Pharma's Total Receivables of $0.02 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on OKYO Pharma and its competitors. OKYO Pharma's current Total Receivables is $0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OKYO Pharma stock overvalued right now?
OKYO Pharma (OKYO) has a current Total Receivables of $0.02 Mil. The current Total Receivables is $0.02 Mil. OKYO Pharma's overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For OKYO Pharma (OKYO), the current Total Receivables is $0.02 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OKYO Pharma Business Description

Address 14/15 Conduit Street, Floor 4, London, GBR, W1S 2XJ
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
23GF Score

Get the complete analysis for OKYO

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.69
Price